









Markets
/
Stocks
/
nasdaq-apdn
/

Applied DNA Sciences Inc

APDN

5.620USD

0.000

Close 11/04, 16:00（ET）Quotes delayed by 15 min

5.07MMarket Cap

LossP/E TTM



Applied DNA Sciences Inc

5.620

0.000

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Applied DNA Sciences Inc

Currency: USD Updated: 2025-10-06

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a . Despite a strong stock market performance, the company shows strong fundamentals and technicals, which don't support the current strong trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Applied DNA Sciences Inc's Score

Industry at a Glance

Industry Ranking

152 / 207

Overall Ranking

517 / 4706

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 0 analysts

Current Rating

0.000

Target Price

0.00%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Applied DNA Sciences Inc Highlights

StrengthsRisks

Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.

Growing

The company is in a growing phase, with the latest annual income totaling USD 3.43M.

Overvalued

The company’s latest PE is 0.00, at a high 3-year percentile range.

Institutional Buying

The latest institutional holdings are 89.41K shares, increasing 42.30% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 0.00 shares of this stock.

Financial Health

Currency: USD Updated: 2025-10-06

Its latest quarterly revenue reached 304.39K, representing a year-over-year decrease of 61.83%, while its net profit experienced a year-over-year decrease of 1134.45%.

Score

Industry at a Glance

Previous score

5.88

Change



Financials



Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings



Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency



Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential



Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns



Key Metrics

Free cash flow

No Data

Applied DNA Sciences Inc's Company Valuation

Currency: USD Updated: 2025-10-06

The company’s current valuation score is 7.96, which is higher than the Healthcare Equipment & Supplies industry's average of 7.17. Its current P/E ratio is 0.00, which is 0.00% below the recent high of 0.00 and 296226068.75% above the recent low of -4739.62.

Score

Industry at a Glance

Previous score

7.96

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 152/207

No Data

Earnings Forecast

Currency: USD Updated: 2025-10-06

There is no earnings forecast score for this company; the Healthcare Equipment & Supplies industry's average is 7.71.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

No Data

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-06

The company’s current price momentum score is 1.88, which is lower than the Healthcare Equipment & Supplies industry's average of 6.88. Sideways: Currently, the stock price is trading between the resistance level at 7.75 and the support level at 2.88, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

1.59

Change

0.29

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(1)

Buy(5)

Indicators

Value

Direction

MACD(12,26,9)

0.514

Buy

RSI(14)

68.132

Neutral

STOCH(KDJ)(9,3,3)

49.183

Buy

ATR(14)

0.836

High Vlolatility

CCI(14)

148.930

Buy

Williams %R

35.172

Buy

TRIX(12,20)

1.451

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

4.472

Buy

MA10

4.057

Buy

MA20

3.406

Buy

MA50

3.635

Buy

MA100

3.802

Buy

MA200

4.678

Buy

Institutional Confidence

Currency: USD Updated: 2025-10-06

The latest institutional shareholding proportion is 1.51%, representing a quarter-over-quarter decrease of 77.54%. The largest institutional shareholder is The Vanguard, holding a total of 0.00 shares, representing 0.00% of shares outstanding, with 100.00% decrease in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Anson Funds Management LP.

46.51K

+918.33%

Sabby Management, LLC

24.36K

+249.63%

Jantzen (Beth M)

3.00

Shorrock (Clay)

4.00

UBS Financial Services, Inc.

11.13K

+381.65%

UBS Switzerland AG

493.00

Tower Research Capital LLC

222.00

+593.75%

SBI Securities Co., Ltd.

146.00

+117.91%

Grossman (Bruce)

111.00

Sanctuary Advisors, LLC

20.00

Risk Assessment

Currency: USD Updated: 2025-10-06

The company’s current risk assessment score is 2.05, which is lower than the Healthcare Equipment & Supplies industry's average of 4.58. The company's beta value is 0.13. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.